PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity ...
15hon MSN
We recently published a list of 10 Most Undervalued High Quality Stocks to Buy According to Analysts. In this article, we are ...
The Targeted Pulse: New Trial Evaluating Iadademstat/Azacitidine in MDS and Positive Trends in HNSCC
Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results